PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments fo...Show More
investor of
competitor of
Metrics
marketSTOCKS
msh_idCOM:PTCBIO
localeus
websitehttps://www.ptcbio.com/
ipo_date2013-06-20
primary_stock_msh_idNASDAQ:PTCT
source_reff29aaf06-f6c5-46a7-a2d2-ba1903d80ddc
products_or_servicesTransformative therapies for rare diseases, clinical trial research.